Valneva SE (EPA:VLA)
3.696
-0.088 (-2.33%)
Sep 5, 2025, 5:35 PM CET
Valneva SE Revenue
Valneva SE had revenue of 48.33M EUR in the quarter ending June 30, 2025, with 26.98% growth. This brings the company's revenue in the last twelve months to 196.33M, up 25.47% year-over-year. In the year 2024, Valneva SE had annual revenue of 169.58M with 10.32% growth.
Revenue (ttm)
196.33M
Revenue Growth
+25.47%
P/S Ratio
3.23
Revenue / Employee
280.47K
Employees
713
Market Cap
634.72M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 169.58M | 15.87M | 10.32% |
Dec 31, 2023 | 153.71M | -207.59M | -57.46% |
Dec 31, 2022 | 361.30M | 13.22M | 3.80% |
Dec 31, 2021 | 348.09M | 237.76M | 215.52% |
Dec 31, 2020 | 110.32M | -15.88M | -12.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 10.59M |
Virbac | 1.40B |
Valneva SE News
- 7 hours ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN - Benzinga
- 2 days ago - VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 3 days ago - Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate - GlobeNewsWire
- 11 days ago - Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy • news - Onvista
- 12 days ago - Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday - Benzinga
- 12 days ago - Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday - Benzinga
- 12 days ago - Johnson Fistel Investigates Valneva Following FDA Suspension - GlobeNewsWire
- 12 days ago - Safety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In US - Benzinga